Blog Archives

Trial Cost Gets Hot

I could not resist the temptation to title this blog post “Trial Cost Gets Hot” given it’s August and temperatures are soaring in places like San Antonio Texas and Death Valley (where by the way you can jump into an all-natural “hot springs” pool to “cool” off. But to jump right in to this topic, I want to discuss how pleased we were to publish some top line results on the cost of clinical trials recently in Nature Review Drug Discovery. At the time of authoring the article, I didn’t realize it would stir such strong opinions and reactions about how much trials cost, or at least how much we think they cost

But whatever your current understanding of the cost of clinical trials, we believe the time is right for companies to start measuring and analyzing the cost of clinical trials and to begin more thoughtful dialogue on what it means….what it means to be a high cost company; or what it means to be an efficient company.

The bottom line is that wherever your company sits on this pendulum is only the start of the discussion and the interpretation depends on what question you are trying to answer or what your company is trying to achieve.

Benchmarking cost at an individual trial level takes a bit of effort and maybe even a little trial and error, but when done right, it can be an extremely powerful tool in shaping and driving performance. Indeed, cost is a lever in not only efficiency, but also in getting drugs to market faster.

Only by having access to this type of reliable cost data using a framework that can help the discussion can you start to gain insight into differing strategies and their results.

We start our next round of Trial Cost this month. Hope you can join us.

Carpe diem!

Linda Martin
President and Founder
KMR Group

We Started A Blog

I am pleased to start this blog for KMR Group. It’s an opportunity for me and others at KMR Group to share some inside thoughts on our work….thoughts that may never make it into a publication or a report. And to address questions or add to the dialogue on a variety of performance or analytics based topics from R&D productivity to site performance possibly in some far flung corner of the world.

We hope these short, concise ideas add to your understanding of R&D performance.

Carpe diem!

Linda Martin
President and Founder
KMR Group

SiteView Application Released


Sites Holiday Billboard

Clinical Advantage combines high level strategy with actionable metrics to improve clinical performance. Through studies and applications, clinical advantage offers companies the means to address cycle time, trial cost, productivity, outsourcing and white space.


KMR’s rich data sources and experience, and comprehensive tools can benefit your company’s development. In many areas, in many ways


  • Enrollment Metrix
  • Enrollment Forecasting
  • Best Places For Clinical Research
  • Study Startup Evaluation
  • Country Selection Evaluation
Enhance study startup and optimize enrollment performance. Invaluable for clinical trial strategy and planning, country selection, forecasting, startup, and feasibility.


  • Site Scorecard
  • Site Metrix
  • Site Contracts
  • Site Performance Study
  • Site Selection Evaluation
  • Site Metrix For Sites
Applications and reports for site planning, site selection, and improving performance and timelines.
Used to select top performing sites. Used to engage with sites.


  • CRO Metrix Application
  • Outsourcing Performance Assessment
Resources to help understand outsourced study expectations and performance improvement


  • Trial Cost Metrix Application
  • Trial Cost Study
  • Project Cost Application
  • Project Cost Study
Understand the cost of clinical trials or projects by myriad components. Access current cost benchmarks and inform your clinical trial and portfolio cost strategies.

Cycle Time

  • Cycle Time Metrix
  • Cycle Time Program
  • Clinical Performance Scorecard
KMR Group’s Cycle Time program offers a comprehensive solution to both evaluate cycle time performance and to make available data for use in day-to-day decision making